Use this comparison to prepare better questions for your care team
There is, however, evidence that its active ingredient, Semaglutide, can be used as a weight-loss treatment in various clinical trials and studies such as Ghusn et al (2022) and a clinical trial by Wilding et al (2021)
According to the 2020 ADA Standards of Medical Care in Diabetes, his revascularization procedure in January 2019 is a clinical trigger to consider the addition of a glucose-lowering agent with evidence of cardiovascular benefit
What Do Studies Say About the Long-Term Effects of Semaglutide and Topiramate
It is identical to the native GLP-1, except for the replacement of lysine with arginine at position 34 and the attachment of a palmitic acid to lysine at position 26
Tesamorelin users may see more dramatic visceral fat reduction at this stage because the compound acts directly on VAT